Clinical Trial

Same-day Radioembolization for Large HCC

Study acronym: ISTAR-01
Recruiting
View on ClinicalTrials.gov →
Summary
In patients who has no sign suggesting high lung shunt fraction (TIPS, hepatic vein invasion, hepatic vein enhancement on arterial phase, dysmorphic intratumoral vessel), planning angiography, MAA scan, and radioembolization are performed in a single day with SIR-Spheres. This prospective registry will prove that the selection criteria is accurate and same-day radioembolization is feasible and safe.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2025-04-23; most recent amendment 2026-04-05.
Status change: Not Yet Recruiting → Recruiting 2025-05-01
Trial Details
NCT Number NCT06944483
Lead Sponsor Seoul National University Hospital
Conditions Hepatocellular Carcinoma (HCC)
Enrollment 138 participants
Start Date 2025-04-25
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-09